EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The prevalence of the AR-V7 variant and its association with clinicopathologic characteristics in non-prostatic cancers—a systematic review

Zaineh Alnoubani iD, Youssuf Khanafer iD, Adnan Fojnica iD, Emir Begagic iD, Inga Rose iD, Zoran Gatalica iD, Semir Vranic iD

Carcinogenesis · 07.07.2026 · 47 (3)

DOI: 10.1093/carcin/bgag052 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Carcinogenesis, online erschienen am 04.08.2026. Verfasst von Zaineh Alnoubani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, PO Box 2713, 2713 Doha, Qatar. Hauptthemen laut MEDLINE: Receptors, Androgen, Neoplasms, Biomarkers, Tumor, Breast Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Library.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Androgen receptor splice variant 7 (AR-V7) is associated with resistance to androgen receptor-targeting therapies in prostate cancer, but its prevalence and clinical relevance in non-prostatic cancers remain incompletely characterized. A systematic review was conducted in accordance with PRISMA guidelines. Thirty-four studies, including 4855 clinical cases and 60 cell lines, were included. Overall, AR-V7 positivity was reported in 948/4855 clinical cases (19.5%); however, this represents a descriptive estimate across heterogeneous tumor types, study designs, and detection methods. Breast cancer accounted for 4057 of 4855 clinical cases (83.6%) and 815 of 948 AR-V7-positive cases (86.0%), with a within-cancer prevalence of 20.1%. However, after excluding the TCGA cohort in which AR-V7 was inferred through splice-junction analysis, the prevalence of AR-V7-positive breast cancer decreased to 9%. Higher tumor-specific proportions were observed in salivary duct carcinoma (55.2%), hepatocellular carcinoma (57.1%), and non-muscle-invasive bladder cancer (82.6%), but these estimates were based on smaller cohorts and should be interpreted cautiously. AR-V7 was present in several treatment-naive non-prostatic cancers, suggesting that it may represent a preexisting molecular feature in selected contexts. Current evidence suggests that AR-V7 warrants further investigation as a candidate biomarker. Standardized detection methods and prospective studies are needed before its clinical utility can be established.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenNeoplasmsBiomarkers, TumorBreast NeoplasmsHumansFemalePrevalenceMaleProtein Isoforms

Stichwörter der Autor:innen

AR-V7androgen receptornon-prostatic cancerssystematic reviewtherapeutic resistance

Substanzen

Receptors, AndrogenAR protein, humanBiomarkers, TumorProtein Isoforms

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, PO Box 2713, 2713 Doha, Qatar.
  • Institute of Virology, TUM School of Medicine, Technical University of Munich, Trogerstraße 30, 81675 Munich, Germany.
  • Department of Neurosurgery, Cantonal Hospital Zenica, Crkvice 67, 72000 Zenica, Bosnia and Herzegovina.
  • Reference Medicine, 4050 E Cotton Center Blvd Bldg 3 Suite 38, 85040 Phoenix, AZ, United States.

ORCID-Profile: Zaineh Alnoubani, Youssuf Khanafer, Adnan Fojnica, Emir Begagic, Inga Rose, Zoran Gatalica, Semir Vranic

Förderung

  • Qatar National Library

Zitieren

APA

Alnoubani, Z., Khanafer, Y., Fojnica, A., Begagic, E., Rose, I., Gatalica, Z., & Vranic, S. (2026). The prevalence of the AR-V7 variant and its association with clinicopathologic characteristics in non-prostatic cancers—a systematic review. Carcinogenesis, 47(3). https://doi.org/10.1093/carcin/bgag052

Vancouver

Alnoubani Z, Khanafer Y, Fojnica A, Begagic E, Rose I, Gatalica Z, et al. The prevalence of the AR-V7 variant and its association with clinicopathologic characteristics in non-prostatic cancers—a systematic review. Carcinogenesis. 2026;47(3). doi:10.1093/carcin/bgag052

BibTeX
@article{Alnoubani2026,
  author = {Alnoubani, Zaineh and Khanafer, Youssuf and Fojnica, Adnan and Begagic, Emir and Rose, Inga and Gatalica, Zoran and Vranic, Semir},
  title = {The prevalence of the AR-V7 variant and its association with clinicopathologic characteristics in non-prostatic cancers—a systematic review},
  journal = {Carcinogenesis},
  year = {2026},
  volume = {47},
  number = {3},
  doi = {10.1093/carcin/bgag052}
}
Kostenlos starten →